Format
Sort by

Send to

Choose Destination

Links from HomoloGene

Items: 1 to 20 of 24

1.

Overlapping region of p53/wrap53 transcripts: mutational analysis and sequence similarity with microRNA-4732-5p.

Pouladi N, Kouhsari SM, Feizi MH, Gavgani RR, Azarfam P.

Asian Pac J Cancer Prev. 2013;14(6):3503-7.

2.

Association of common WRAP 53 variant with ovarian cancer risk in the Polish population.

Mędrek K, Magnowski P, Masojć B, Chudecka-Głaz A, Torbe B, Menkiszak J, Spaczyński M, Gronwald J, Lubiński J, Górski B.

Mol Biol Rep. 2013 Mar;40(3):2145-7. doi: 10.1007/s11033-012-2273-9. Epub 2012 Nov 29.

3.
4.

Anthracyclines induce the accumulation of mutant p53 through E2F1-dependent and -independent mechanisms.

Bug M, Dobbelstein M.

Oncogene. 2011 Aug 18;30(33):3612-24. doi: 10.1038/onc.2011.72. Epub 2011 Mar 28.

PMID:
21441950
5.

WRAP53 promotes cancer cell survival and is a potential target for cancer therapy.

Mahmoudi S, Henriksson S, Farnebo L, Roberg K, Farnebo M.

Cell Death Dis. 2011 Jan 13;2:e114. doi: 10.1038/cddis.2010.90.

6.

Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita.

Zhong F, Savage SA, Shkreli M, Giri N, Jessop L, Myers T, Chen R, Alter BP, Artandi SE.

Genes Dev. 2011 Jan 1;25(1):11-6. doi: 10.1101/gad.2006411.

7.

WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies.

Mahmoudi S, Henriksson S, Weibrecht I, Smith S, Söderberg O, Strömblad S, Wiman KG, Farnebo M.

PLoS Biol. 2010 Nov 2;8(11):e1000521. doi: 10.1371/journal.pbio.1000521.

8.

The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer.

Farnebo M, Bykov VJ, Wiman KG.

Biochem Biophys Res Commun. 2010 May 21;396(1):85-9. doi: 10.1016/j.bbrc.2010.02.152. Review.

PMID:
20494116
9.

Wrap53, a novel regulator of p53.

Farnebo M.

Cell Cycle. 2009 Aug;8(15):2343-6. Epub 2009 Aug 8.

PMID:
19571673
10.

TCAB1: driving telomerase to Cajal bodies.

Venteicher AS, Artandi SE.

Cell Cycle. 2009 May 1;8(9):1329-31. Epub 2009 May 23.

PMID:
19342896
11.

A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis.

Venteicher AS, Abreu EB, Meng Z, McCann KE, Terns RM, Veenstra TD, Terns MP, Artandi SE.

Science. 2009 Jan 30;323(5914):644-8. doi: 10.1126/science.1165357.

12.

Telomerase recruitment requires both TCAB1 and Cajal bodies independently.

Stern JL, Zyner KG, Pickett HA, Cohen SB, Bryan TM.

Mol Cell Biol. 2012 Jul;32(13):2384-95. doi: 10.1128/MCB.00379-12. Epub 2012 Apr 30.

13.

Cajal bodies and histone locus bodies in Drosophila and Xenopus.

Nizami ZF, Deryusheva S, Gall JG.

Cold Spring Harb Symp Quant Biol. 2010;75:313-20. doi: 10.1101/sqb.2010.75.005. Epub 2010 Nov 3.

PMID:
21047905
14.

The diversity profile of TP53 is influenced by positive selection on the immediately upstream locus WDR79.

Alonso S, Izagirre N, López S, Smith-Zubiaga I, Hervella M, Boyano MD, Arroyo-Berdugo Y, Gardeazabal J, Díaz-Ramón JL, Sánchez Díez A, Careaga JM, de la Rúa C.

Hum Hered. 2010;69(1):34-44. doi: 10.1159/000243152. Epub 2009 Oct 2.

PMID:
19797907
15.

Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage.

Mahmoudi S, Henriksson S, Corcoran M, Méndez-Vidal C, Wiman KG, Farnebo M.

Mol Cell. 2009 Feb 27;33(4):462-71. doi: 10.1016/j.molcel.2009.01.028.

16.

Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer.

Garcia-Closas M, Kristensen V, Langerød A, Qi Y, Yeager M, Burdett L, Welch R, Lissowska J, Peplonska B, Brinton L, Gerhard DS, Gram IT, Perou CM, Børresen-Dale AL, Chanock S.

Int J Cancer. 2007 Dec 1;121(11):2532-8.

17.

Large-scale evaluation of candidate genes identifies associations between DNA repair and genomic maintenance and development of benzene hematotoxicity.

Lan Q, Zhang L, Shen M, Jo WJ, Vermeulen R, Li G, Vulpe C, Lim S, Ren X, Rappaport SM, Berndt SI, Yeager M, Yuenger J, Hayes RB, Linet M, Yin S, Chanock S, Smith MT, Rothman N.

Carcinogenesis. 2009 Jan;30(1):50-8. doi: 10.1093/carcin/bgn249. Epub 2008 Oct 31.

18.

Dyskeratosis Congenita.

Savage SA.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2016.
2009 Nov 12 [updated 2016 May 26].

19.

Identification of Gnr1p, a negative regulator of G alpha signalling in Schizosaccharomyces pombe, and its complementation by human G beta subunits.

Goddard A, Ladds G, Forfar R, Davey J.

Fungal Genet Biol. 2006 Dec;43(12):840-51. Epub 2006 Aug 1.

PMID:
16884933
20.

A conserved WD40 protein binds the Cajal body localization signal of scaRNP particles.

Tycowski KT, Shu MD, Kukoyi A, Steitz JA.

Mol Cell. 2009 Apr 10;34(1):47-57. doi: 10.1016/j.molcel.2009.02.020. Epub 2009 Mar 12.

Items per page

Supplemental Content

Write to the Help Desk